Polycyclic indazole derivatives and their use as ERK inhibitors for the treatment of cancer

Details for Australian Patent Application No. 2008262412 (hide)

Owner SCHERING CORPORATION

Inventors Shipps Jr., Gerald W.; Cooper, Alan; Desai, Jagdish; Shih, Neng-Yang; Deng, Yongqi; Kelly, Joseph; Zhu, Hugh; Gao, Xiaolei; Tsui, Hon-Chung; Zhu, Liang; Patel, Mehul; Nan, Yang; Wang, James; Boga, Sobhana Babu; Doll, Ronald; Alhassan, Abdul-Basit; Paliwal, Sunil

Agent Griffith Hack

Pub. Number AU-A-2008262412

PCT Pub. Number WO2008/153858

Priority 11/810,282 05.06.07 US

Filing date 4 June 2008

Wipo publication date 18 December 2008

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/444 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 491/056 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2008/153858 Priority application(s): WO2008/153858

7 January 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 Dec 2009

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008262421-Improved ventilator apparatus

2008262406-Tricyclic anilide heterocyclic CGRP receptor antagonists